Table 2.
Comparison of VM and VM-associated proteins between triple-negative and non-triple-negative breast cancer cases.
| Factors | TNBC (%) 67 | non-TNBC (%) 10 | X2 | P |
|---|---|---|---|---|
| VM | ||||
| Negative | 43 (64.2) | 88 (82.2) | 5.237 | 0.002** |
| Positive | 24 (35.8) | 19 (17.8) | ||
| HIF-1α | ||||
| Negative | 24 (35.8) | 49 (45.8) | 1.276 | 0.259 |
| Positive | 43 (64.2) | 58 (54.2) | ||
| MMP2 | ||||
| Negative | 12 (21.1) | 42 (39.3) | 3.687 | 0.050* |
| Positive | 45 (78.9) | 65 (60.7) | ||
| VE-cadherin | ||||
| Negative | 23 (57.5) | 37 (74.0) | 3.977 | 0.046* |
| Positive | 17 (42.5) | 13 (26.0) | ||
| Twist1 | ||||
| Negative | 22 (55.0) | 38 (76.0) | 6.810 | 0.009** |
| Positive | 18 (45.0) | 12 (24.0) |
*
means P < 0.05,
**
means P < 0.01.